Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. raised its holdings in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) by 4.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 753,001 shares of the company’s stock after purchasing an additional 31,966 shares during the period. Charles Schwab Investment Management Inc. owned 0.41% of Doximity worth $32,808,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the business. Farther Finance Advisors LLC grew its holdings in shares of Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after buying an additional 1,193 shares during the last quarter. Quarry LP grew its holdings in shares of Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after buying an additional 131,253 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in shares of Doximity during the first quarter valued at $46,000. Finally, First Horizon Advisors Inc. grew its holdings in shares of Doximity by 80.0% during the second quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock valued at $48,000 after buying an additional 760 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Stock Up 1.5 %

DOCS opened at $54.20 on Wednesday. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75. The company has a 50-day moving average price of $46.10 and a 200 day moving average price of $36.39. The company has a market cap of $10.12 billion, a PE ratio of 58.69, a price-to-earnings-growth ratio of 4.28 and a beta of 1.40.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. KeyCorp raised shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective on the stock in a report on Friday, November 8th. Robert W. Baird upped their price target on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a report on Tuesday, September 17th. Truist Financial upped their price target on shares of Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a report on Thursday, November 14th. Evercore ISI upped their price target on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Finally, Baird R W raised shares of Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Eleven investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $52.27.

Get Our Latest Stock Analysis on DOCS

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Articles

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.